{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T21:16:25Z","timestamp":1773263785354,"version":"3.50.1"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"5","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01-AI082229"],"award-info":[{"award-number":["U01-AI082229"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30-AI036214"],"award-info":[{"award-number":["P30-AI036214"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-AI111435"],"award-info":[{"award-number":["R01-AI111435"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32-HL098062"],"award-info":[{"award-number":["T32-HL098062"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9,1]]},"DOI":"10.1093\/cid\/cix422","type":"journal-article","created":{"date-parts":[[2017,4,29]],"date-time":"2017-04-29T03:10:07Z","timestamp":1493435407000},"page":"772-778","source":"Crossref","is-referenced-by-count":13,"title":["Impact of Fluoroquinolone Use on Mortality Among a Cohort of Patients With Suspected Drug-Resistant Tuberculosis"],"prefix":"10.1093","volume":"65","author":[{"given":"Marva","family":"Seifert","sequence":"first","affiliation":[{"name":"Department of Medicine, University of California, San Diego, La Jolla;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophia B","family":"Georghiou","sequence":"additional","affiliation":[{"name":"Foundation for Innovative New Diagnostics, Geneva, Switzerland; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard S","family":"Garfein","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, San Diego, La Jolla;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald","family":"Catanzaro","sequence":"additional","affiliation":[{"name":"University of Arkansas, Fayetteville"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy C","family":"Rodwell","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, San Diego, La Jolla;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,5,5]]},"reference":[{"key":"key\n\t\t\t\t20180328142324_CIT0001","volume-title":"Global tuberculosis report 2015","author":"World Health Organization","year":"2015"},{"key":"key\n\t\t\t\t20180328142324_CIT0002","volume-title":"Global tuberculosis report 2016","author":"World Health Organization","year":"2016"},{"key":"key\n\t\t\t\t20180328142324_CIT0003","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1183\/09031936.00077307","article-title":"Clinical and operational value of the extensively drug-resistant tuberculosis definition","volume":"30","author":"Migliori","year":"2007","journal-title":"Eur Respir J"},{"key":"key\n\t\t\t\t20180328142324_CIT0004","doi-asserted-by":"crossref","first-page":"e6914","DOI":"10.1371\/journal.pone.0006914","article-title":"Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis","volume":"4","author":"Johnston","year":"2009","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180328142324_CIT0005","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/S0140-6736(13)62675-6","article-title":"Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: a cohort study","volume":"383","author":"Pietersen","year":"2014","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180328142324_CIT0006","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ijmyco.2015.03.005","article-title":"Factors associated with treatment success and death in cases with multidrug-resistant tuberculosis in Bulgaria, 2009\u20132010","volume":"4","author":"Milanov","year":"2015","journal-title":"Int J Mycobacteriol"},{"key":"key\n\t\t\t\t20180328142324_CIT0007","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(06)69573-1","article-title":"Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa","volume":"368","author":"Gandhi","year":"2006","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180328142324_CIT0008","doi-asserted-by":"crossref","first-page":"969","DOI":"10.5588\/ijtld.15.0123","article-title":"Treatment outcomes for HIV and MDR-TB co-infected adults and children: systematic review and meta-analysis","volume":"19","author":"Isaakidis","year":"2015","journal-title":"Int J Tuberc Lung Dis"},{"key":"key\n\t\t\t\t20180328142324_CIT0009","doi-asserted-by":"crossref","first-page":"e0128907","DOI":"10.1371\/journal.pone.0128907","article-title":"Factors associated with unfavorable treatment outcomes in new and previously treated TB patients in Uzbekistan: a five year countrywide study","volume":"10","author":"Gadoev","year":"2015","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180328142324_CIT0010","doi-asserted-by":"crossref","first-page":"e0119332","DOI":"10.1371\/journal.pone.0119332","article-title":"Mortality among MDR-TB cases: comparison with drug-susceptible tuberculosis and associated factors","volume":"10","author":"Chung-Delgado","year":"2015","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180328142324_CIT0011","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1586\/14787210.5.3.385","article-title":"Lethal interaction: the colliding epidemics of tobacco and tuberculosis","volume":"5","author":"Pai","year":"2007","journal-title":"Expert Rev Anti Infect Ther"},{"key":"key\n\t\t\t\t20180328142324_CIT0012","doi-asserted-by":"crossref","first-page":"e1001932","DOI":"10.1371\/journal.pmed.1001932","article-title":"Association between regimen composition and treatment response in patients with multidrug-resistant tuberculosis: a prospective cohort study","volume":"12","author":"Yuen","year":"2015","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t20180328142324_CIT0013","doi-asserted-by":"crossref","first-page":"e0159827","DOI":"10.1371\/journal.pone.0159827","article-title":"The effectiveness and safety of fluoroquinolone-containing regimen as a first-line treatment for drug-sensitive pulmonary tuberculosis: a systematic review and meta-analysis","volume":"11","author":"Lee","year":"2016","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180328142324_CIT0014","first-page":"CD004795","article-title":"Fluoroquinolones for treating tuberculosis (presumed drug-sensitive)","author":"Ziganshina","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20180328142324_CIT0015","doi-asserted-by":"crossref","first-page":"339","DOI":"10.5588\/ijtld.14.0814","article-title":"Concordance of Mycobacterium tuberculosis fluoroquinolone resistance testing: implications for treatment","volume":"19","author":"Farhat","year":"2015","journal-title":"Int J Tuberc Lung Dis"},{"key":"key\n\t\t\t\t20180328142324_CIT0016","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1128\/AAC.02583-13","article-title":"Moxifloxacin retains antimycobacterial activity in the presence of gyrA mutations","volume":"58","author":"McGrath","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180328142324_CIT0017","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1086\/653115","article-title":"Treatment outcomes among patients with extensively drug-resistant tuberculosis: systematic review and meta-analysis","volume":"51","author":"Jacobson","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328142324_CIT0018","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/S0140-6736(10)60492-8","article-title":"Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study","volume":"375","author":"Dheda","year":"2010","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180328142324_CIT0019","doi-asserted-by":"crossref","first-page":"525","DOI":"10.5588\/ijtld.14.0739","article-title":"Changes in treatment outcomes of multidrug-resistant tuberculosis","volume":"19","author":"Kwak","year":"2015","journal-title":"Int J Tuberc Lung Dis"},{"key":"key\n\t\t\t\t20180328142324_CIT0020","doi-asserted-by":"crossref","first-page":"4496","DOI":"10.1128\/AAC.00506-13","article-title":"Impact of fluoroquinolone resistance on bactericidal and sterilizing activity of a moxifloxacin-containing regimen in murine tuberculosis","volume":"57","author":"Fillion","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180328142324_CIT0021","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.1128\/AAC.00968-10","article-title":"Should moxifloxacin be used for the treatment of extensively drug-resistant tuberculosis? An answer from a murine model","volume":"54","author":"Poissy","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180328142324_CIT0022","volume-title":"Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis","year":"2014"},{"key":"key\n\t\t\t\t20180328142324_CIT0023","volume-title":"WHO treatment guidelines for drug-resistant tuberculosis\u20142016 update","author":"World Health Organization","year":"2016"},{"key":"key\n\t\t\t\t20180328142324_CIT0024","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1136\/thoraxjnl-2015-207638","article-title":"Survival of patients with multidrug-resistant TB in Eastern Europe: what makes a difference?","volume":"71","author":"Balabanova","year":"2016","journal-title":"Thorax"},{"key":"key\n\t\t\t\t20180328142324_CIT0025","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1186\/1745-6215-15-434","article-title":"The Global Consortium for Drug-Resistant Tuberculosis Diagnostics (GCDD): design of a multi-site, head-to-head study of three rapid tests to detect extensively drug-resistant tuberculosis","volume":"15","author":"Hillery","year":"2014","journal-title":"Trials"},{"key":"key\n\t\t\t\t20180328142324_CIT0026","doi-asserted-by":"crossref","first-page":"e0136861","DOI":"10.1371\/journal.pone.0136861","article-title":"Performance comparison of three rapid tests for the diagnosis of drug-resistant tuberculosis","volume":"10","author":"Catanzaro","year":"2015","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180328142324_CIT0027","author":"World Health Organization","year":"2008"},{"key":"key\n\t\t\t\t20180328142324_CIT0028","author":"Stop TB Partnership"},{"key":"key\n\t\t\t\t20180328142324_CIT0029","doi-asserted-by":"crossref","first-page":"39","DOI":"10.5588\/ijtld.13.0307","article-title":"Treatment outcomes and moxifloxacin susceptibility in ofloxacin-resistant multidrug-resistant tuberculosis","volume":"18","author":"Jo","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"key\n\t\t\t\t20180328142324_CIT0030","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1183\/09031936.00134712","article-title":"Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes","volume":"42","author":"Falzon","year":"2013","journal-title":"Eur Respir J"},{"key":"key\n\t\t\t\t20180328142324_CIT0031","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/cid\/civ910","article-title":"Multidrug-resistant tuberculosis treatment outcomes in relation to treatment and initial versus acquired second-line drug resistance","volume":"62","author":"Cegielski","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328142324_CIT0032","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1086\/522537","article-title":"Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis","volume":"45","author":"Kim","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328142324_CIT0033","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2334-14-5","article-title":"Tuberculosis mortality: patient characteristics and causes","volume":"14","author":"Lin","year":"2014","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20180328142324_CIT0034","doi-asserted-by":"crossref","first-page":"e77979","DOI":"10.1371\/journal.pone.0077979","article-title":"Nutritional status of adult patients with pulmonary tuberculosis in rural central India and its association with mortality","volume":"8","author":"Bhargava","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180328142324_CIT0035","doi-asserted-by":"crossref","first-page":"e39443","DOI":"10.1371\/journal.pone.0039443","article-title":"Tobacco use or body mass\u2014do they predict tuberculosis mortality in Mumbai, India? Results from a population-based cohort study","volume":"7","author":"Pednekar","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180328142324_CIT0036","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1086\/590005","article-title":"Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis","volume":"47","author":"Kwon","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328142324_CIT0037","doi-asserted-by":"crossref","first-page":"e82943","DOI":"10.1371\/journal.pone.0082943","article-title":"Risk factors for poor treatment outcomes in patients with MDR-TB and XDR-TB in China: retrospective multi-center investigation","volume":"8","author":"Tang","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180328142324_CIT0038","doi-asserted-by":"crossref","first-page":"943","DOI":"10.4269\/ajtmh.13-0011","article-title":"Weight gain and response to treatment for multidrug-resistant tuberculosis","volume":"89","author":"Gler","year":"2013","journal-title":"Am J Trop Med Hyg"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/65\/5\/772\/24266329\/cix422.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T01:26:55Z","timestamp":1750210015000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/65\/5\/772\/3798529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,5]]},"references-count":38,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,5,5]]},"published-print":{"date-parts":[[2017,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/cix422","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,9,1]]},"published":{"date-parts":[[2017,5,5]]}}}